Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Simms

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Plos One|June 29, 2021
HAI-1 is an independent predictor of lung cancer mortality and is required for M1 macrophage polarizationStanley Borowicz, Daniel R Principe, Matthew J Dorman, et al.
The Journal of Infectious Diseases|June 1, 1984
Dengue virus type 2 vaccine: reactogenicity and immunogenicity in soldiersW H Bancroft, R M Scott, K H Eckels, et al.
Cancer Immunology, Immunotherapy : CII|June 22, 2017
Critical biological parameters modulate affinity as a determinant of function in T-cell receptor gene-modified T-cellsTimothy T Spear, Yuan Wang, Kendra C Foley, et al.
Nature Communications|April 4, 2025
Probing the subtle differences between promethium and curiumTrenton B Vogt, Megan E Simms, Connor J Parker, et al.
Chemical Science|July 26, 2024
PYTA: a universal chelator for advancing the theranostic palette of nuclear medicineMegan E Simms, Zhiyao Li, Megan M Sibley, et al.
Cell Metabolism|February 21, 2017
Excessive Respiratory Modulation of Blood Pressure Triggers HypertensionClément Menuet, Sheng Le, Bowen Dempsey, et al.
Cancer Immunology, Immunotherapy : CII|February 5, 2016
TCR gene-modified T cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumorsTimothy T Spear, Glenda G Callender, Jeffrey J Roszkowski, et al.
Angewandte Chemie (International Ed. in English)|January 29, 2025
Towards the Stable Chelation of Radioantimony(V) for Targeted Auger TheranosticsAeli P Olson, Briana R Schrage, Md Faizul Islam, et al.
Journal of Leukocyte Biology|February 28, 2016
Hepatitis C virus-cross-reactive TCR gene-modified T cells: a model for immunotherapy against diseases with genomic instabilityTimothy T Spear, Timothy P Riley, Gretchen E Lyons, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Plos One|June 29, 2021
HAI-1 is an independent predictor of lung cancer mortality and is required for M1 macrophage polarizationStanley Borowicz, Daniel R Principe, Matthew J Dorman, et al.
The Journal of Infectious Diseases|June 1, 1984
Dengue virus type 2 vaccine: reactogenicity and immunogenicity in soldiersW H Bancroft, R M Scott, K H Eckels, et al.
Cancer Immunology, Immunotherapy : CII|June 22, 2017
Critical biological parameters modulate affinity as a determinant of function in T-cell receptor gene-modified T-cellsTimothy T Spear, Yuan Wang, Kendra C Foley, et al.
Nature Communications|April 4, 2025
Probing the subtle differences between promethium and curiumTrenton B Vogt, Megan E Simms, Connor J Parker, et al.
Chemical Science|July 26, 2024
PYTA: a universal chelator for advancing the theranostic palette of nuclear medicineMegan E Simms, Zhiyao Li, Megan M Sibley, et al.
Cell Metabolism|February 21, 2017
Excessive Respiratory Modulation of Blood Pressure Triggers HypertensionClément Menuet, Sheng Le, Bowen Dempsey, et al.
Cancer Immunology, Immunotherapy : CII|February 5, 2016
TCR gene-modified T cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumorsTimothy T Spear, Glenda G Callender, Jeffrey J Roszkowski, et al.
Angewandte Chemie (International Ed. in English)|January 29, 2025
Towards the Stable Chelation of Radioantimony(V) for Targeted Auger TheranosticsAeli P Olson, Briana R Schrage, Md Faizul Islam, et al.
Journal of Leukocyte Biology|February 28, 2016
Hepatitis C virus-cross-reactive TCR gene-modified T cells: a model for immunotherapy against diseases with genomic instabilityTimothy T Spear, Timothy P Riley, Gretchen E Lyons, et al.
Pageof 6